All posts by imreal

“HEAL THE HEALERS NOW” New Initiative by the David Lynch Foundation and US TM Organization to Provide Meditation to US Medical Professionals Battling COVID-19


“Heal the Healers Now,” a new national initiative to bring the stress-reducing Transcendental Meditation (TM) technique to medical professionals who are battling the coronavirus pandemic, was launched today by two nonprofit groups: the Center for Health and Wellness of the David Lynch Foundation and the US TM Organization.

A New York Times article published on March 31 titled “Nurses Die, Doctors Fall Sick and Panic Rises on Virus Front Lines,” reported that “The coronavirus pandemic, which has infected more than 30,000 people in New York City, is beginning to take a toll on those who are most needed to combat it: the doctors, nurses and other workers at hospitals and clinics. In emergency rooms and intensive care units, typically dispassionate medical professionals are feeling panicked as increasing numbers of colleagues get sick.”

“With COVID-19 testing our healthcare system’s technology, infrastructure and most importantly human resources, the doctors and nurses taking care of the scared and sick patients – at great risk to themselves – deserve the very best tools to manage their health that we can provide them,” said Bob Roth, Chief Executive Officer, the David Lynch Foundation.

“Throughout the years, 5,000 doctors and nurses have learned the TM technique. The goal of the David Lynch Foundation is to teach many thousands more of these heroes over the coming year.”

“Save the doctors, save the nurses!” said filmmaker David Lynch, chair of the David Lynch Foundation. “This initiative will teach these courageous healthcare providers Transcendental Meditation so they can strengthen their immune systems, stay safe and continue to help others.”

Even before the pandemic, a Harvard report called physician burnout “a public health crisis that urgently demands action,” with several surveys putting the rate of provider burnout as high as 70 percent. The American Academy of Family Physicians linked burnout to higher rates of medical errors, substance abuse and addiction and suicide among physicians.

Today, the situation is far worse and demands well-documented, innovative approaches to address this crisis. “Transcendental Meditation is an evidence-based, non-pharmacological intervention for this devastating public health crisis,” said Stuart Rothenberg, MD, Medical Director of the Center for Health and Wellness.

“The Center for Health and Wellness has a long track record of providing TM instruction to first responders, including police, firefighters, and military personnel. Today, our doctors, nurses, and other healthcare providers are true first responders—they are on the frontlines in a literal life-or-death battle against a pandemic that threatens the very life of society,” Dr. Rothenberg said.

Heal the Healers Fund

The Center has established the “Heal the Healers Now Fund” with all money raised used to deliver the meditation to healthcare providers at no charge. Those interested in supporting the initiative can visit HealTheHealersNow.org.

Deep relaxation and stress reduction

Transcendental Meditation is an easy-to-learn, enjoyable-to-practice mental technique for deep relaxation and stress-reduction that has been successfully offered in medical schools, academic and VA medical centers, hospitals, military academies, substance abuse centers, prisons and other settings, according to the TM.org website.

Instruction in the TM technique for healthcare providers includes eight hours of specialized training by a trauma-informed teacher, which includes one class of personalized instruction, as well as a comprehensive, one-year follow up program to ensure the provider is gaining maximum results. The technique is practiced for 15-20 minutes twice a day. Training will begin once health authorities give the greenlight for teaching medical workers onsite.

Celebrities including Jerry Seinfeld, Ellen DeGeneres, Oprah Winfrey, Katy Perry, Tom Hanks, Hugh Jackman, Patrick Stewart, Paul McCartney, Ringo Starr, Sting, Russell Brand, Laura Dern, Lena Dunham, Naomi Watts, Mary-Louise Parker, Amy Schumer and Bill Hader practice Transcendental Meditation and support the work of the David Lynch Foundation to bring the meditation for free to at-risk adults and youth.

Unique state of “restful alertness”

“TM produces a unique neurophysiological state that combines deep metabolic rest with heightened mental alertness. This state of deep relaxation, which researchers have termed ‘restful alertness,’ is a potent antidote to stress,” Dr. Rothenberg said.

Over 400 peer-reviewed published studies on TM have documented improvements in a wide variety of stress-related disorders, as well as significant improvements in cognitive function and overall health and well-being. The National Institutes of Health and the Department of Defense have awarded nearly $30 million in grant support for research on TM.

For example, a recent $2.4 million study funded by the Department of Defense found TM markedly reduced symptoms of PTSD among meditating veterans. Results of the randomized controlled trial were published in The Lancet Psychiatry in November 2018.

Ten million people of all ages, nationalities and religions, including tens of thousands of healthcare providers, have learned TM. The TM-based “Healthcare Provider Wellness Program” has been offered in hospitals and clinics nationwide, most recently at Weill Cornell Medical Center-New York Presbyterian Hospital in New York City, with significant reductions in physician burnout, insomnia and symptoms of post-traumatic stress over a three-month period in those practicing the TM technique.

Eric J. Nestler, MD, PhD, Director of the Friedman Brain Institute at the Icahn School of Medicine at Mount Sinai in New York, learned TM six years ago. “TM has tremendous potential for healthcare providers to reduce burnout and increase job satisfaction and productivity,” Dr. Nestler said.

Patty J. Lee, MD, is Chief of the Division of Pulmonary, Allergy and Critical Care at Duke University Medical Center in Durham, North Carolina. “I am leading an entire division of physicians through this CoV19 crisis—and TM has been my anchor. I am now petitioning our entire health system to train all our healthcare providers in TM,” Dr. Lee said.

Track record in healthcare programs

The TM technique has been adopted in healthcare provider wellness programs as a stand-alone approach or as an adjuvant therapy to make existing programs more effective. These programs include:


  • Loyola University’s Stritch School of Medicine in Chicago Medical students are offered a for-credit elective program entitled, “Physician Wellness through Transcendental Meditation.” To date, more than 350 medical students have learned TM, with more students learning all the time based on positive reports. A randomized controlled trial of 42 academic faculty physicians at Loyola Stritch performed over a four-month period found significant improvements in overall burnout, depression and insomnia in the TM group compared to controls.
  • Weill Cornell Medical Center-New York Presbyterian Hospital in New York City A pilot study of physicians in the Emergency Medicine Department found significant reductions in physician burnout, insomnia and symptoms of post-traumatic stress over a three-month period in those practicing TM.
  • Norwich University in Northfield, Vermont A six-year study on cadets at America’s oldest military college (and the home of ROTC) has found significant reductions in perceived stress, hyper-vigilance and depression, and increases in psychological resilience in TM participants.

Donating services to healthcare providers

Dr. Rothenberg said the “Heal the Healers Now Fund” will allow certified TM teachers to provide the instruction to learn to meditate at no cost to doctors, nurses and other workers, as well as offer a comprehensive, one-year follow up program to ensure the providers are gaining maximum benefit from their practice.

For more information, and to make a tax-deductible donation to “Heal the Healers Now Fund,” please visit HealTheHealersNow.org or contact Heroes@DavidLynchFoundation.org

For media inquiries, contact Dan Knitzer at The TASC Group at dan@thetascgroup.com or 973-978-3956.

Thermal Camera Offers Group Temperature Screening with A.I. Facial Detection


Automatic snapshot when abnormal body temperature is detected

Automatic snapshot when abnormal body temperature is detected

Personnel can obtain accurate readings while adhering to social distancing requirements with a detection range of 2.6′ – 10.5′.

TEquipment announces the introduction of the Fotric 226B Thermal Camera which offers group temperature screening using A.I. Facial Detection for elevated or abnormal skin temperature.

The Fotric 226B is an efficient and streamlined solution designed to simplify the task of temperature monitoring and identifying subjects displaying abnormal readings. This product can be used to screen large groups of people simultaneously. Through its powerful A.I. face detection module, the Fotric 226B is able to automatically detect and screen individuals as they pass through its field of view. Check out this video to see it in action.

With a detection range of 2.6 to 10.5 feet, personnel are able to obtain accurate readings while adhering to social distancing requirements. The Fotric 226B can be placed at the head of a queue and will alert personnel when its temperature alarm has been triggered.

The Fotric 226B comes with the manufacturer’s WLIR software package as a standard item. WLIR has a built-in A.I. facial detection module, which automatically locks onto faces in the camera’s view for temperature measurement. It will also intelligently shield non-facial sources of high temperature. The WLIR has a built-in skin temperature calibration algorithm which automatically adjusts based on environmental conditions. This helps prevent false positives from fluctuations in morning and evening temperature. The WLIR software can also automatically count the number of screened personnel and suspected abnormal skin temperature alarms.

Highlighted features of the Fotric 226B include:

  • Automatically locks face temperature to prevent false alarms
  • A.I.-based face detection
  • Intelligent temperature calibration algorithm to prevent false negatives
  • Screen and alarm statistics
  • Automatic temperature alarm
  • Automatic photo of detected person with abnormal skin temp

The Fotric 226B is now available from TEquipment

Please note, these products are designed to screen temperature. They cannot be used to detect or diagnose COVID-19/Coronavirus.

Share article on social media or email:

Curiox Biosystems and STEMCELL Technologies Announce Method to Safely Prepare COVID-19 Blood Samples for Vaccine Research


News Image

“We are always aspiring to help scientists perform their research in a more accurate and safe manner” said Dr. Namyong Kim, CEO of Curiox Biosystems.

Curiox Biosystems in conjunction with STEMCELL Technologies today announced a new system that will help researchers develop vaccines to SARS-CoV-2, the virus that causes COVID-19.

A new configuration of the Laminar Wash™ HT1000 System will allow scientists to completely process blood samples from COVID-19 positive patients in a safe environment. The package will consist of an updated Laminar Wash HT1000 system, Buffer Exchanger, and STEMCELL Technologies’ EasySep™ RBC Depletion Reagent.

Laminar Wash technology enables researchers to more accurately study immune responses for vaccine research and clinical trials without the need for centrifugation, eliminating the aerosolization of potentially infectious samples. Laminar Wash technology is especially helpful in flow cytometry applications in vaccine research. The new HT1000 configuration allows containment of blood samples within a biosafety cabinet, ensuring the protection of laboratory staff and other samples.

“We are always aspiring to help scientists perform their research in a more accurate and safe manner” said Dr. Namyong Kim, CEO of Curiox Biosystems.

Traditionally, unwanted red blood cells (RBCs) are removed from blood samples using lysis buffers, which can be harmful to white blood cells, the cells responsible for immune response. By working with STEMCELL Technologies’ RBC depletion kits, researchers can easily remove unwanted RBCs from blood samples without the need for lysis, resulting in superior data quality.

“It is always a proud moment when the reagents and tools we develop can help enable scientific discoveries and treatments. This new application will facilitate the safe processing of blood samples so that researchers can better understand the immune response to current and future infectious disease outbreaks” said Dr. Andy Kokaji, Director of Immunology at STEMCELL Technologies.

Enabling safe and efficient handling of virus-positive blood samples ultimately helps patients by accelerating treatment and vaccine research. The new package of products is available starting, March 23, 2020. Curiox and STEMCELL Technologies are offering to assist institutions in obtaining the product as easily as possible, with donations considered in some cases.

About Curiox Biosystems

Curiox Biosystems is a bioinstrumentation company spun out of the Agency for Science, Technology, and Research (A*STAR) in Singapore. Curiox has become a leader in the development and commercialization of innovative assay platforms based on its expertise in surface chemistry and engineering. Curiox’s vision is to accelerate the progress of life sciences, drug discovery and diagnostics through the miniaturization and improved automation of bioassays.

About STEMCELL Technologies

STEMCELL Technologies is Canada’s largest biotechnology company. STEMCELL supports life sciences research with high-quality cell culture media, cell separation technologies, instruments, accessory products, and educational resources. STEMCELL’s products are used globally by scientists advancing the stem cell, immunology, cancer, regenerative medicine, microbiology, and cellular therapy fields. Find more information at http://www.stemcell.com

Share article on social media or email:

AssuredPartners Acquires Early, Cassidy & Schilling, LLC


News Image

“This partnership will strengthen our Maryland operations as we continue to expand our services and grow throughout this part of the region,” said AssuredPartners President and COO Tom Riley. We are pleased to have the clients and team of EC&S join AssuredPartners.”

AssuredPartners, Inc. is pleased to announce the acquisition of Early, Cassidy & Schilling, LLC (EC&S) of Rockville, MD. EC&S has been a trusted insurance advisor in Maryland since its founding in 1927. New York based advisory services firm, Dowling Hales, advised EC&S in the sale and the international law firm of McDermott Will & Emory acted as legal advisor to EC&S throughout the acquisition. The team of 32 will remain under the operational leadership of Matarie M. Broom. The agency currently reports $10 million in annualized revenues.

“EC&S delivers client solutions with clarity, honesty and a sense of urgency. These values align with AssuredPartners operations and we look forward to our new partnership with the team in the Maryland marketplace,” said AssuredPartners Regional President Brian Bair.

AssuredPartners President and COO Tom Riley said, “This partnership will strengthen our Maryland operations as we continue to expand our services and grow throughout this part of the region. EC&S provides cost-effective innovative services with an uncompromising dedication to exceed customer service expectations. We are pleased to have the clients and team of EC&S join AssuredPartners.”

For more information on Early, Cassidy & Schilling, LLC, please visit: http://www.ecsinsure.com.

ABOUT ASSUREDPARTNERS, INC

Headquartered in Lake Mary, Florida and led by Jim Henderson and Tom Riley, AssuredPartners, Inc. acquires and invests in insurance brokerage businesses (property and casualty, employee benefits, surety and MGU’s) across the United States and in London. From its founding in March of 2011, AssuredPartners has grown to over $1.5 billion in annualized revenue and continues to be one of the fastest growing insurance brokerage firms in the United States with over 180 offices in 30 states and London. For more information, please contact Dean Curtis, CFO, at 407.708.0031 or dean.curtis@assuredpartners.com, or visit http://www.assuredpartners.com.

Share article on social media or email:

Andrea Anderson to Head SkyWater Search Partners’ Expanded HR Recruiting Practice


Human Resources Recruiter Andrea Anderson

Andrea Anderson, Sr. Associate – Human Resources

Today, more than ever, businesses are leaning on their HR leaders to navigate through a host of challenges from changing legislation, to hiring strategies and employee engagement.

SkyWater Search Partners is pleased to welcome Andrea Anderson to lead our newly expanded Human Resources placement practice area. With sixteen years of experience in human resources and recruiting leadership roles, Andrea is uniquely qualified to join and lead SkyWater’s rapidly expanding HR practice area.

“The HR practice at SkyWater has been growing very quickly over the past few years, completing roles anywhere from the HR Manager level to CHRO. We determined that our next phase of growth in this space would come from a leader within the HR industry with a strong executive recruiting background, but also someone that has exceptional functional HR expertise who knows the in’s and out’s of the ever-changing HR world. Someone that knows how to identify strong HR talent, and someone that clients enjoy partnering with on a personal level. With that in mind, we couldn’t be more excited to have Andrea join the SkyWater team and lead our HR practice!

“I’ve worked with Andrea from a client perspective for a while, and have seen her outstanding abilities as an executive recruiter, valued relationship partner, and most importantly, her values as a person. When we had the opportunity to bring her over to the executive search side to lead our HR practice, we jumped at the chance. We’re looking forward to seeing Andrea drive continued growth in one of our fastest-growing practice areas at SkyWater!”

– Adam Hoffarber, Partner

Before joining SkyWater, Andrea spent seven years at Securian Financial in several HR leadership roles and led their Executive Recruitment function for the past two years. Prior to that, she was a recruiting expert with Travelers. She is a graduate of the University of Minnesota and holds an SPHR certification.

“As a career HR practitioner, I understand the unique challenges facing the HR function and the impact the right HR hire can make on an organization. Today, more than ever, businesses are leaning on their HR leaders to navigate through a host of challenges from changing legislation, to hiring strategies and employee engagement. My aim is to be an added and continued resource for businesses needing to make the perfect hire today. I’m thrilled to lead the HR practice area and join the talented SkyWater team; they are truly the best in the business.”

– Andrea Anderson, Senior Associate, Human Resources

About SkyWater Search Partners: SkyWater is the #1 ranked executive search firm in the Twin Cities metro and tri-state area. Practice areas include Accounting & Finance, Information Technology, Engineering, Operations & Supply Chain, Sales, Marketing, Human Resources, Consumer Packaged Goods, and Construction.

Follow SkyWater Search Partners on LinkedIn

https://www.linkedin.com/company/skywater-search-partners

Share article on social media or email:

MolecularMatch Releases Support for Coronavirus


“Our team has been working overtime to add support for coronavirus and COVID-19 clinical trials and publications,” said Eric Pulaski, CEO of MolecularMatch.

MolecularMatch, a leading clinical informatics company providing Precision Medicine software solutions, has updated the MolecularMatch search engine with new features and content to support customers’ response to the novel coronavirus pandemic. Updates include access to hundreds of clinical trials and thousands of publications that are applicable to coronavirus and COVID-19.

With the built-in search features of the MolecularMatch search engine, users can locate the most appropriate clinical trials and publications for individual patients, including filtering clinical trials for inclusion and exclusion criteria based on patient-specific clinical details and narrowing search results to trial sites by a patent’s geographic location. Institutions can also upload private trials to the MolecularMatch database that are not yet indexed in the public registries.

“Our team has been working overtime to add support for coronavirus and COVID-19 clinical trials and publications,” said Eric Pulaski, CEO of MolecularMatch. “Although the focus of our curated content has been on oncology, the versatility of our core platform enabled us to quickly add support for new content in this area of infectious disease. We’re stepping up to the plate to do our part to support researchers, labs, healthcare providers, and others in the global fight against the novel Coronavirus pandemic.”

Version 4.1 of the company’s web-based portal (MMPortal) and REST API (MMPower) are available immediately, and all current customers have access to the new content at no additional charge. The MolecularMatch Knowledge Graph and content across the MolecularMatch knowledgebase have been enhanced with the following:

  • Added support for antiviral drugs and drug classes
  • Added virology, emergency medicine and infectious disease related journals and publications (over 2,300 publication entries)
  • Added global registry clinical trials related to coronavirus/COVID-19 (over 360 trials)
  • MolecularMatch’s clinical comprehension and ranking applied to this new data

The MolecularMatch COVID-19 database is updated every 2-3 days. The company is also exploring other ways to help battle this pandemic with new offerings to reach a wider base of users who can benefit from the MolecularMatch search engine.

About MolecularMatch

MolecularMatch, Inc. is a Houston, Texas based clinical informatics SaaS company established in 2014. The company was founded on the vision of using tumor molecular profiling and outcomes from previously-treated patients to provide the best personalized treatment for current patients. MolecularMatch delivers personalized, evidence-based therapeutic guidance and clinical trials matched to each patient. Customers include molecular labs, health information systems, biopharma, second opinion and payer companies, as well as cancer centers across the globe. Visit us at molecularmatch.com or follow us on Twitter or LinkedIn.

Share article on social media or email:

PAX Technology and Sound Payments Recognized for Providing an Optimal Tap to Pay Point of Sale Experience


In places such as gas stations where convenience and time are of the essence, a fast and easy payment experience should be readily available for customers

The Visa U.S. Qualified Tap to Pay Point of Sale Program recognizes point of sale providers ready and equipped to provide a consistent and improved tap to pay checkout experience. PAX and Sound Payments’ Tap to Pay Point of Sale solution showcases the PAX IM20 and Aries8 retrofitted in a gas pump and demonstrates the software providing the tap experience followed by a transaction for gas and convenience items like food and beverage.

This solution allows any gas station to more cost-effectively and easily migrate to EMV Pay-At-The-Pump for both contact and contactless payments. The solution can be deployed for both inside the convenience store or outside at the gas pump. PAX IM20 and Aries8 are both certified to process EMV transactions at the pump and will allow any gas station to satisfy the EMV Migration Deadline for Pay-At-The-Pump coming up in October 1st, 2020.

Requiring no signature or PIN, the easy nature of the tap to pay checkout experience allows the customer to focus on their purchases rather than expect a slew of prompts such as “insert card, remove card, enter PIN” and so on.

“In places such as gas stations where convenience and time are of the essence, a fast and easy payment experience should be readily available for customers,” says Andy Chau, President & CEO of PAX Technology. “We’re honored to have our combined solution with Sound Payments recognized by Visa as an optimal Tap to Pay Point of Sale Experience.”

“With PAX’s secure hardware and Sound Payment’s software solution, we offer a customer-centric Tap to Pay experience that will soon have customers wanting to tap more at every point of sale,” says Andrew Russell, the CEO of Sound Payments. “This award is made possible by our investment in experts and research to ensure the best contactless customer experience at the pump.”

By following the Visa’s guidelines for an optimal Tap to Pay Point of Sale experience, PAX and Sound Payments maintain the consistency required to ensure the point of sale delivers a fast, easy, and secure payment experience for customers.

About Sound Payments

Sound Payments is a multi-channel, diversified technology company that creates simplified, innovative solutions in the payments, petroleum and financial services industries. Petro Solutions provides technology solutions for the petroleum industry, including EMV Easy Pump™, which enables stations to cost-effectively install a retrofit solution at the pump that solves EMV. For more information, visit http://www.SoundPayments.com.

About PAX Technology Inc.

PAX Technology is one of the fastest-growing electronic payment solution providers in the world. PAX has been serving the global retail marketplace for over 20 years and has distribution in over 120 countries shipping over 50 million terminals worldwide. PAX offers a complete line of products and services supported by extensive R&D capabilities. In addition to a most competitive pricing model, quality assurance is the company’s top priority, which enables PAX to have a strong advantage in the marketplace.

Share article on social media or email:

New Study Accurately Predicts Pregnant Woman’s Risk of Spontaneous Very Preterm Birth


Nixxi, a biotech company deeply committed to tackling and improving human behavior and biological conditions through advanced analytics, announces the results of new research on its preterm birth biomarkers in the peer-reviewed publication Human Reproduction Open. The study demonstrates that a ratio of maternal steroid hormones, when tested in the first trimester, accurately predicts a pregnant woman’s risk for having a spontaneous preterm birth prior to 32 weeks (called “very preterm birth”). Babies born at less than 32 weeks have higher rates of complications and a greater likelihood of long-term care needs, and these pregnancy outcomes result in significant costs to the healthcare system. The findings are important as early detection allows clinicians to identify those women at the greatest risk for preterm delivery and implement behavioral and clinical interventions to mitigate risk.

“Nixxi has taken a fresh look at more than 40 years of research in the area of preterm birth to identify opportunities to advance the science,” said Avi Patil, MD, Nixxi founder and chief executive officer. “By utilizing an advanced targeted steroid metabolic approach, our team discovered an imbalance in hormonal pathways highly correlated to preterm delivery resulting in a promising new test that can be used early in pregnancy to identify women at risk for spontaneous preterm delivery less than 32 weeks’ gestation. This data will arm healthcare providers with valuable insights on identifying their at-risk patient population and proactively caring for these patients with heightened needs.”

About the Study

Ninety-three pregnant women who had plasma samples obtained during the late first trimester/early second trimester were included in the study. Of those women:

  •     28 delivered prior to 32 weeks
  •     40 delivered between 33-37 weeks
  •     25 delivered after 37 weeks


Plasma samples were processed for mass spectroscopy and the amount of progesterone and progesterone metabolites in the samples were measured. Mean values of each measured steroid metabolite were calculated and compared among women delivering less than 32 weeks, less than 37 weeks and greater than 37 weeks. Maternal serum levels of 11-deoxycorticsterone (DOC) measured during the late first trimester or early second trimester correlate with an increased risk for preterm delivery prior to 32 weeks. When the ratio of DOC to 16-alpha-hydroxyprogesterone was measured, the association with delivery prior to 32 weeks was stronger.

About Preterm Birth

Preterm birth is defined as the delivery of a baby before 37 completed weeks of pregnancy. A full-term pregnancy term lasts between 37-40 weeks or about nine months. Preterm babies tend to have more health problems and stay in the hospital longer than babies born full-term. The earlier in pregnancy a baby is born, the greater the chance of serious health problems, both immediate and long-term, including slower growth, cerebral palsy, sudden infant death syndrome (SIDS), diseases of the ears and eyes and even blindness.

Preterm birth affects one in 10 pregnancies in the U.S. and the overall rate has continued to increase for the past four consecutive years. Preterm birth and its complications are the largest contributors to infant death in the U.S. and globally. In the U.S. alone, the annual economic burden associated with preterm birth amounts to $26.2 billion. The majority of these costs stem from those babies born before 32 weeks.

Common causes of preterm birth include a woman having had multiple pregnancies, infections and chronic conditions such as diabetes and high blood pressure. There could also be shared genetic factors among family members that affect risk. Women who live in poverty, both in low-income countries and more developed nations, also have a much higher risk. Often, however, no cause will be identified.

Other known risk factors for preterm birth include having had a prior preterm birth, pregnancy with twins or other multiples, a short interval between pregnancies, fertility treatments, and problems with the major organs involved in the pregnancy. Smoking, drug use, inability in maintaining a healthy weight and stress can all contribute to preterm birth risk as well. Lifestyle choices and decision-making play a critical role in eliminating some of these risk factors and give women a better chance of having a healthy pregnancy and baby.

About Nixxi

Nixxi, based in Phoenix, AZ, is a biotech company deeply committed to tackling and improving human behavior and biological conditions through advanced analytics, led by a group of experienced, determined professionals with a variety of healthcare backgrounds.

Nixxi’s mission is to reduce pregnancy risk and enhance neonatal outcomes through early and cost-effective testing paired with actionable insights for physicians and patients.

For more information or to see the full study, please go to http://www.nixxihealth.com.

# # #

Share article on social media or email:

Maptycs Selected as Hot 100 InsureTech Company


As the world continues to face greater levels of risk including pandemics like the novel coronavirus, technologies built on big data analytics like Maptycs are crucial in helping insurance companies gain actionable insights.

Today, Maptycs (http://www.maptycs.com), an insurtech company that uses geospatial visualization and advanced analytics technology to help insurance professionals better assess property risk exposure, map assets against natural perils, and monitor severe weather events in real-time, announced it had been selected by Intelligent Insurer as a Hot 100 company. Announced in late 2019, the 100 insurtech firms were chosen based on each company’s ability to make a tangible and positive difference to aspects of the risk transfer industry globally, according to Intelligent Insurer.

“We are thrilled to have been included in the Hot 100 InsurTech list,” said Jacqueline Legrand, Founder and CEO of Maptycs. “As the world continues to face greater levels of risk including pandemics like the novel coronavirus, technologies built on big data analytics like Maptycs are crucial in helping insurance companies gain actionable insights. The explosion in volume of external risk data now enables businesses to monitor and mitigate the impacts of large-scale events as they unfold, and more effectively assess the effectiveness of their response efforts in real-time. As an example, several Maptycs clients currently use our cloud-based Geographic Information System to track COVID-19 spread, gain visibility into its potential impact on their business and adjust their risk strategies accordingly.”

According to the Intelligent Insurer story, the list was compiled based on the results of a global survey prompting their readers to nominate companies they have been impressed with. The survey was also complemented by the work of the organization’s in-house research team and the knowledge of its editorial staff.

To view the Intelligent Insurer Insurtech Hot 100 online directory, visit:

https://www.intelligentinsurer.com/listing/insurtechhot100

About Maptycs

Maptycs is a data analytics and geospatial visualization solution for the commercial insurance industry. Through its next-generation platform, Maptycs combines big data technology and a proprietary 100% cloud-based Geographic Information System (GIS) enabling insurance professionals to capture, combine and analyze increasingly complex risk data from multiple sources and formats in real-time, bringing a more impactful understanding of their property risk exposure and vulnerabilities. Risk managers can more effectively define risk retention, mitigation and transfer strategies, optimize total cost of risk and manage business continuity planning. Underwriters can more confidently assess risk to compute premiums and place adequate reinsurance, while setting timely and adequate reserves, resulting in improved underwriting profits and a positive contribution to the company rating. Visit http://www.maptycs.com for more information.

Share article on social media or email:

CommLoan, Leading CRE Lending Marketplace, Welcomes John Dorsey as President


I believe CommLoan is in a position to disrupt the ideology of a fragmented commercial lending market through technology designed to improve the borrowers’ experience with the lenders.”

CommLoan, a leading CRE lending tech company connecting borrowers to lenders, just announced John Dorsey as the President of Sales and Business Development. John will be responsible for the leadership of the CommLoan sales team, developing new business opportunities, and working alongside CEO Mitch Ginsberg on strategic direction of the company.

Dorsey has more than 20 years of senior management experience, including 15 years of business relationship development and plan execution at a national multi-family utility billing service company. Most recently, he was Chief Sales Officer of Conservice, LLC.

“I am very excited to have John Dorsey as a member of the CommLoan team,” said Mitch Ginsberg, CEO and founder of CommLoan. As CommLoan continues its rapid growth and focuses on expansion to new US markets, John’s sales leadership and his strong background in building top performing sales teams will accelerate CommLoan’s growth. We are thrilled to have him onboard!” stated Mitch.

“I am honored to be joining the CommLoan team,” said John Dorsey. “I believe CommLoan has a great business model with a talented management team, contributing to its unique position to capitalize on the everchanging commercial lending environment. As technological utilization continually evolves to optimize business transactions, the commercial mortgage industry is being left behind. This is why CommLoan introduced a new way of streamlining the borrowers’ experience through the CUPID (Commercial Underwriting Pricing Index Data) platform. I believe CommLoan is in a position to disrupt the ideology of a fragmented commercial lending market through technology designed to improve the borrowers’ experience with the lenders.”

As one of the original founders and Chief Sales Officer of Conservice, Dorsey successfully grew revenue from 0 to 80+ million. He led the company through strategic partnerships, led them to win numerous notable service awards and industry recognition before exiting through a private equity acquisition of Conservice.

Dorsey earned a BA Degree in Geography from Arizona State University and an MBA in International Business from Grand Canyon University. Prior to his formal education, John Dorsey proudly served his country in the US Army Armored Division.

About CommLoan

Founded in 2014, CommLoan is the true commercial real estate lending marketplace with the innovative platform CUPID. CommLoan has streamlined the multifaceted process of obtaining commercial real estate financing. With the touch of a button, CUPID can sort through hundreds of lenders and thousands of loan programs to find the right loan that fits borrowers’ specific needs. Combined with concierge service throughout the process, leaves the borrower with a world class lending experience. Further information about how CommLoan’s technology disrupts the commercial real estate mortgage industry, please visit https://www.commloan.com

Share article on social media or email: